News & Updates
Filter by Specialty:
Pemafibrate superior to conventional fibrates in T2DM
Treatment with pemafibrate in patients with type 2 diabetes mellitus (T2DM) yields more favourable effects on lipid profile, as well renal function, as compared with conventional fibrates, a study has found.
Pemafibrate superior to conventional fibrates in T2DM
01 Oct 2022
Alcohol consumption ups risk of CVD, all-cause mortality in men
Recent evidence suggests that drinking alcoholic beverages is associated with cardiovascular diseases (CVD), including coronary artery disease (CAD), and all-cause mortality.
Alcohol consumption ups risk of CVD, all-cause mortality in men
01 Oct 2022
Deucravacitinib bests placebo, apremilast in moderate-to-severe plaque psoriasis
Treatment with deucravacitinib achieves better efficacy than placebo and apremilast in patients with moderate-to-severe plaque psoriasis, while also yielding a good safety profile, reports a recent study.
Deucravacitinib bests placebo, apremilast in moderate-to-severe plaque psoriasis
01 Oct 2022
Absence of standard modifiable cardiovascular risk factors tied to poor outcomes in type 2 AMI
Among patients with type 2 acute myocardial infarction (AMI), the absence of standard modifiable cardiovascular risk factors (SMuRF) appears to worsen poor outcomes, such as mortality, stroke, and major adverse cardiovascular and cerebrovascular events (MACCE), a new study has found.
Absence of standard modifiable cardiovascular risk factors tied to poor outcomes in type 2 AMI
01 Oct 2022
AF increases susceptibility to stroke associated with air pollution exposure
Atrial fibrillation (AF) exacerbates the effect of air pollution exposure on acute ischaemic stroke outcomes, such that AF patients are more likely to develop stroke when exposed to increasing levels of smog (O3) and carbon monoxide (CO) compared with those who have no AF, according to a Singapore study.